Iannis Aifantis, PhD, Appointed Chair, Department Of Pathology
NYU Langone Medical Center is pleased to announce that Iannis Aifantis, PhD, professor of pathology and member of the NYU Cancer Institute, was appointed chair of the Department of Pathology.
“Iannis is an accomplished leader, a gifted scientist and generous colleague,” said Robert Grossman, MD, dean and CEO, NYU Langone Medical Center. “He has the skill, vision, and experience to build on the long and proud history of our Department of Pathology and guide it to even greater success in the coming years.”
Dr. Aifantis is an internationally recognized immunologist and cancer biologist, specializing in the investigation of T cell acute leukemia (T-ALL), a common form of childhood leukemia. His work has provided significant contributions to the understanding of T-ALL and to the development of new and better treatments for the disease. In addition, his laboratory focuses on studying the subtle molecular signaling events that shape how blood stem cells mature into a variety of cells in the immune system, and how those cells can undergo malignant transformation. These insights may provide additional methods to combat blood cancers in both children and adults.
Born in Greece, Dr. Aifantis earned his BS degree in biology and an MS degree in molecular biology and genetics from the University of Crete. He received a Marie Curie Fellowship and enrolled at the University of Paris V, where he did his doctoral studies in the laboratory of immunologist Harald von Boehmer. As a postdoctoral fellow, he followed Dr. von Boehmer to the Dana-Farber Cancer Institute and the Harvard Medical School and later established his own laboratory at the University of Chicago School of Medicine. He joined the faculty at the NYU School of Medicine in 2006.
The recipient of numerous awards and honors, Dr. Aifantis was named a Howard Hughes Medical Institute Early Career Scientist in 2009, a program that provides support to 50 of this nation’s most outstanding and creative early career faculty. His also received the American Cancer Society Research Scholar Award, a Cancer Research Institute Young Investigator Award, the Sidney Kimmel Foundation for Cancer Research Scholar Award, the Society for Hematology and Stem Cells McCulloch and Till Award, the Leukemia & Lymphoma Society Scholar Award, the Dana Foundation Neuro-Immunology Award, and The Vilcek Prize for Creative Promise in Biomedical Science.
The Department of Pathology at NYU Langone has roots based in the foundation of the New York University Medical College in the mid 1800s, and today proudly maintains more than 100 faculty who serve both as clinicians and scientists who continue a long and illustrious history, currently ranking among the top ten pathology departments by NIH awards. The Department's growth is based in a strongly integrative approach that provides a juncture of clinical and basic science for translational research. This approach ensures future pathologists the ability to move easily between the foundations of basic research, translational science and clinical medicine.